Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 1

Status

Terminated 6Recruiting 6Active not recruiting 6Completed 3Withdrawn 2Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 5Thoracic 1

Conditions

Breast Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Triple Negative Breast Neoplasms 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 144Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Mastectomy, Segmental × Clear all
NCT01234532 2022-05-03

0927GCC

University of Maryland, Baltimore

Phase 2 Terminated
5 enrolled 7 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02907918 2021-09-29

PALTAN

Washington University School of Medicine

Phase 2 Terminated
26 enrolled 8 charts
Breast

Breast Neoplasms

NCT02462200 2020-06-25

SMART

Washington University School of Medicine

Phase 2 Terminated
81 enrolled
Breast

Breast Neoplasms

NCT00290654 2017-12-28

Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
45 enrolled 11 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00238615 2015-05-12

Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC

Stanford University

Phase 2 Terminated
13 enrolled 9 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00082667 2013-02-25

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

Vanderbilt-Ingram Cancer Center

Phase 2 Terminated
1 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡